NINA PATYNOWSKI: Open Payments
NPI 1437563152 · CARSON CITY, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$720 in 13 payments from 9 companies in 2025. Trend: 2023 $555 · 2024 $630 · 2025 $720
Food & beverage: $720
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. | 4 | $205 |
| Mallinckrodt Hospital Products Inc. | 2 | $146 |
| Alexion Pharmaceuticals, Inc. | 1 | $135 |
| Apellis Pharmaceuticals, Inc. | 1 | $96 |
| ABIOMED | 1 | $67 |
| Ardelyx, Inc. | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| SCPHARMACEUTICALS INC. | 1 | $15 |
| Calliditas Therapeutics US Inc. | 1 | $14 |
Products named: ACTHAR, Filspari, ULTOMIRIS, IBSRELA, Kerendia, FUROSCIX, TARPEYO.
Industry payments across NV — which companies pay providers there.
